RecruitingNot ApplicableNCT05486546

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Comparison of Visual Acuity and Quality of Life Following Contoura With Phorcides Compared to WaveLight Wavefront Optimized LASIK

Sponsor

Daniel Terveen

Enrollment

120 participants

Start Date

Aug 15, 2022

Study Type

INTERVENTIONAL

Conditions

Myopia Astigmatism

Summary

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Eligibility

Min Age: 21 YearsMax Age: 38 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Contoura with Phorcides and a medical device called WaveLight Wavefront Optimized for people with astigmatism and myopia. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 21 Years to 38 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.